135 related articles for article (PubMed ID: 26883290)
1. Knockdown of chemokine receptor CXCR4 gene by RNA interference: Effects on the B16-F10 melanoma growth.
André ND; Silva VA; Watanabe MA; De Lucca FL
Oncol Rep; 2016 Apr; 35(4):2419-24. PubMed ID: 26883290
[TBL] [Abstract][Full Text] [Related]
2. In vivo knockdown of CXCR4 using jetPEI/CXCR4 shRNA nanoparticles inhibits the pulmonary metastatic potential of B16‑F10 melanoma cells.
André ND; Silva VA; Ariza CB; Watanabe MA; De Lucca FL
Mol Med Rep; 2015 Dec; 12(6):8320-6. PubMed ID: 26498029
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral injection of PKR shRNA expressing plasmid inhibits B16-F10 melanoma growth.
André ND; Silva VA; Watanabe MA; De Lucca FL
Oncol Rep; 2014 Nov; 32(5):2267-73. PubMed ID: 25175769
[TBL] [Abstract][Full Text] [Related]
4. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells.
Ieranò C; D'Alterio C; Giarra S; Napolitano M; Rea G; Portella L; Santagata A; Trotta AM; Barbieri A; Campani V; Luciano A; Arra C; Anniciello AM; Botti G; Mayol L; De Rosa G; Pacelli R; Scala S
Cell Death Dis; 2019 Jul; 10(8):562. PubMed ID: 31332163
[TBL] [Abstract][Full Text] [Related]
6. Activation of the CXCR4 chemokine receptor enhances biological functions associated with B16 melanoma liver metastasis.
Mendt M; Cardier JE
Melanoma Res; 2017 Aug; 27(4):300-308. PubMed ID: 28445180
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB.
Delgado André N; De Lucca FL
Cancer Lett; 2007 Dec; 258(1):118-25. PubMed ID: 17936498
[TBL] [Abstract][Full Text] [Related]
8. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
Zhang MX; Han N; Yu SY; Leng Y
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
[TBL] [Abstract][Full Text] [Related]
9. Silencing of CXCR4 by RNA interference inhibits cell growth and metastasis in human renal cancer cells.
Wang L; Huang T; Chen W; Gao X; Zhou T; Wu Z; Sun Y
Oncol Rep; 2012 Dec; 28(6):2043-8. PubMed ID: 22972438
[TBL] [Abstract][Full Text] [Related]
10. Effect of short hairpin RNA-induced CXCR4 silence on ovarian cancer cell.
Chen HY; Wang JM; Wang HY; Zhang YX; Liu W; Pan L; Wang WH; Chen SF; Jin WG; Wang L
Biomed Pharmacother; 2012 Oct; 66(7):549-53. PubMed ID: 22902648
[TBL] [Abstract][Full Text] [Related]
11. Effects of CXCR4 gene silencing by lentivirus shRNA on proliferation of the EC9706 human esophageal carcinoma cell line.
Wang DF; Lou N; Qiu MZ; Lin YB; Liang Y
Tumour Biol; 2013 Oct; 34(5):2951-9. PubMed ID: 23744460
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
Cardones AR; Murakami T; Hwang ST
Cancer Res; 2003 Oct; 63(20):6751-7. PubMed ID: 14583470
[TBL] [Abstract][Full Text] [Related]
13. Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2016 Sep; 7(39):64274-64288. PubMed ID: 27590504
[TBL] [Abstract][Full Text] [Related]
14. Gene silencing in primary and metastatic tumors by small interfering RNA delivery in mice: quantitative analysis using melanoma cells expressing firefly and sea pansy luciferases.
Takahashi Y; Nishikawa M; Kobayashi N; Takakura Y
J Control Release; 2005 Jul; 105(3):332-43. PubMed ID: 15936841
[TBL] [Abstract][Full Text] [Related]
15. Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model.
Chen YS; Huang TH; Liu CL; Chen HS; Lee MH; Chen HW; Shen CR
Hum Gene Ther; 2019 Mar; 30(3):273-285. PubMed ID: 30079767
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis.
Aversa I; Zolea F; Ieranò C; Bulotta S; Trotta AM; Faniello MC; De Marco C; Malanga D; Biamonte F; Viglietto G; Cuda G; Scala S; Costanzo F
J Exp Clin Cancer Res; 2017 Aug; 36(1):104. PubMed ID: 28774348
[TBL] [Abstract][Full Text] [Related]
17. Suppression of tumor growth by intratumoral injection of short hairpin RNA-expressing plasmid DNA targeting beta-catenin or hypoxia-inducible factor 1alpha.
Takahashi Y; Nishikawa M; Takakura Y
J Control Release; 2006 Nov; 116(1):90-5. PubMed ID: 17056147
[TBL] [Abstract][Full Text] [Related]
18. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
19. Complete regression of established subcutaneous B16 murine melanoma tumors after delivery of an HIV-1 Vpr-expressing plasmid by in vivo electroporation.
McCray AN; Ugen KE; Muthumani K; Kim JJ; Weiner DB; Heller R
Mol Ther; 2006 Nov; 14(5):647-55. PubMed ID: 16950655
[TBL] [Abstract][Full Text] [Related]
20. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer.
Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S
Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]